Company adopts Edge CTMS in
Medidata is the leading global provider of cloud-based technology and data analytics for clinical research. As Santen strives to globalize its research and development operations, the company will deploy Edge CTMS to streamline trial activities, increase productivity and improve efficiency of trial execution.
Edge CTMS provides real-time visibility into clinical trial milestones, allowing Santen to evaluate operational effectiveness and implement changes rapidly. It also seamlessly integrates with Rave EDC, the industry-leading EDC solution, enabling Santen to dramatically speed trial execution by managing both study and trial data on a single unified platform.
“There is a growing demand to simplify, improve efficiency and create
transparency across clinical trials. The Medidata Edge CTMS solution
makes it possible for life science companies to achieve all three on our
unified platform,” said
As a specialized company dedicated to the ophthalmic field, Santen
carries out research, development, marketing, and sales of
pharmaceuticals. Santen is the market leader in
Medidata's unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world. The Medidata Clinical Cloud® connects patients, physicians and life sciences professionals. Companies on the Medidata platform are individually and collaboratively reinventing the way research is done to create smarter, more precise treatments. For more information: www.mdsol.com